UNITY Biotechnology to Participate in Upcoming March Investor Conferences
Cowen 41st Annual Healthcare Conference
Date:
Presentation Time:
33rd Annual
Date:
Presentation Time:
A live audio webcast of the presentations will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following each event.
About UNITY
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter and LinkedIn.
Investors Gilmartin GroupMatt Lane ir@unitybiotechnology.com MediaCanale Communications Jason Spark Jason.spark@canalecomm.com
Source: Unity Biotechnology, Inc.